Sign in to view content

Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results

Lejla Vajzovic, MD, FASRS

Video
Published 2021

Related

Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2021
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO
Suber S. Huang, MD, MBA, FASRS
Annual Meeting Talks
2021
Performance and Usability of a Self-Operated Home Optical Coherence Tomography (OCT) System: NOTAL-OCT V2.5 (NO V2.5)
Judy E. Kim, MD, FASRS
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more